• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: The heart of NAFLD.社论：非酒精性脂肪性肝病的核心
Front Med (Lausanne). 2023 May 22;10:1209625. doi: 10.3389/fmed.2023.1209625. eCollection 2023.
2
Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.非酒精性脂肪性肝病对疑似冠心病的糖尿病患者心血管事件预测的预后价值：一项前瞻性队列研究。
Cardiovasc Diabetol. 2021 Jan 7;20(1):8. doi: 10.1186/s12933-020-01192-4.
3
Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation.早期非酒精性脂肪性肝病与动脉粥样硬化和炎症的关系。
Clinics (Sao Paulo). 2023 Nov 10;78:100301. doi: 10.1016/j.clinsp.2023.100301. eCollection 2023.
4
Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.酒精性和非酒精性脂肪性肝病与冠状动脉钙化的关系：来自康伯三星健康研究的证据。
Gut. 2019 Sep;68(9):1667-1675. doi: 10.1136/gutjnl-2018-317666. Epub 2018 Nov 24.
5
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease.儿童和青年非酒精性脂肪性肝病患者的心血管疾病风险
Gut. 2023 Mar;72(3):573-580. doi: 10.1136/gutjnl-2022-328105. Epub 2022 Dec 15.
6
The differences between patients with nonalcoholic fatty liver disease (NAFLD) and those without NAFLD, as well as predictors of functional coronary artery ischemia in patients with NAFLD.非酒精性脂肪性肝病（NAFLD）患者与无 NAFLD 患者之间的差异，以及 NAFLD 患者功能性冠状动脉缺血的预测因素。
Clin Cardiol. 2024 Feb;47(2):e24205. doi: 10.1002/clc.24205. Epub 2023 Dec 18.
7
Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.糖尿病、高脂血症、肥胖症和多囊卵巢综合征患者中非酒精性脂肪性肝病的患病率：伊朗北部的一项横断面研究。
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1591-1596. doi: 10.1016/j.dsx.2019.03.009. Epub 2019 Mar 8.
8
Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease.冠心病患者中非酒精性脂肪性肝病的患病率。
ARYA Atheroscler. 2016 Jul;12(4):201-205.
9
Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey.非酒精性脂肪性肝病、心力衰竭与长期死亡率：来自美国国家健康与营养检查调查的见解
Curr Probl Cardiol. 2022 Dec;47(12):101333. doi: 10.1016/j.cpcardiol.2022.101333. Epub 2022 Jul 25.
10
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.

引用本文的文献

1
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions.2025年至2050年亚洲心血管疾病负担：对东亚、南亚、东南亚、中亚和亚太高收入地区的预测分析
Lancet Reg Health West Pac. 2024 Jul 10;49:101138. doi: 10.1016/j.lanwpc.2024.101138. eCollection 2024 Aug.
2
Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH).肥胖与非肥胖代谢功能障碍相关脂肪性肝炎（MASH）住院患者的死亡率、肝失代偿及心血管和肾脏相关结局
Cureus. 2024 May 24;16(5):e60968. doi: 10.7759/cureus.60968. eCollection 2024 May.

本文引用的文献

1
Foregut bypass restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.用于非酒精性脂肪性肝病的前肠转流限制性减肥手术：对3355例个体的荟萃分析
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):658-670. doi: 10.21037/hbsn-21-520. Epub 2022 Jun 20.
2
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-Analysis.非酒精性脂肪性肝病的肝脏、肝外结局及死亡原因——一项荟萃分析系统评价的伞状综述
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):656-665. doi: 10.1016/j.jceh.2022.11.006. Epub 2022 Nov 19.
3
The global burden of metabolic disease: Data from 2000 to 2019.全球代谢性疾病负担：2000 年至 2019 年的数据。
Cell Metab. 2023 Mar 7;35(3):414-428.e3. doi: 10.1016/j.cmet.2023.02.003.
4
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study.肥胖合并营养不良的急性心肌梗死患者的长期预后：一项队列研究。
Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009340. doi: 10.1161/CIRCOUTCOMES.122.009340. Epub 2023 Mar 3.
5
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.204个国家和地区营养不良与肥胖的趋势及预测：基于2019年全球疾病负担研究的分析
EClinicalMedicine. 2023 Feb 16;57:101850. doi: 10.1016/j.eclinm.2023.101850. eCollection 2023 Mar.
6
A two-decade population-based study on the effect of hypertension in the general population with obesity in the United States.一项基于美国普通肥胖人群的为期二十年的高血压影响的人群研究。
Obesity (Silver Spring). 2023 Mar;31(3):832-840. doi: 10.1002/oby.23658. Epub 2023 Feb 7.
7
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.年轻成年人群代谢疾病的全球综合征：来自2000 - 2019年全球疾病负担的趋势与预测联合体
Metabolism. 2023 Apr;141:155402. doi: 10.1016/j.metabol.2023.155402. Epub 2023 Jan 28.
8
The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome.在代谢综合征的定义中纳入非酒精性脂肪性肝病的预后价值。
Aliment Pharmacol Ther. 2023 May;57(9):979-987. doi: 10.1111/apt.17397. Epub 2023 Jan 29.
9
Examining the interim proposal for name change to steatotic liver disease in the US population.探讨美国人群中肝脂肪变性疾病名称变更的临时建议。
Hepatology. 2023 May 1;77(5):1712-1721. doi: 10.1097/HEP.0000000000000043. Epub 2023 Jan 3.
10
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.肝脂肪变性和晚期肝纤维化是急性心肌梗死长期死亡率的独立预测因素。
Diabetes Obes Metab. 2023 Apr;25(4):1032-1044. doi: 10.1111/dom.14950. Epub 2023 Jan 6.

Editorial: The heart of NAFLD.

作者信息

Chew Nicholas W S, Kannan Shankar, Chong Bryan, Chin Yiphan, Muthiah Mark

机构信息

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.

出版信息

Front Med (Lausanne). 2023 May 22;10:1209625. doi: 10.3389/fmed.2023.1209625. eCollection 2023.

DOI:10.3389/fmed.2023.1209625
PMID:37283629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10240047/
Abstract
摘要